Cargando…
The clinical use of pretreatment NLR, PLR, and LMR in patients with esophageal squamous cell carcinoma: evidence from a meta-analysis
BACKGROUND AND PURPOSE: The relationship between neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and lymphocyte to monocyte ratio (LMR) and the prognostic and clinicopathological significance in patients with esophageal squamous cell carcinoma (ESCC) has been reported by ma...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257133/ https://www.ncbi.nlm.nih.gov/pubmed/30538564 http://dx.doi.org/10.2147/CMAR.S171035 |
_version_ | 1783374268255436800 |
---|---|
author | Sun, Yugui Zhang, Lifei |
author_facet | Sun, Yugui Zhang, Lifei |
author_sort | Sun, Yugui |
collection | PubMed |
description | BACKGROUND AND PURPOSE: The relationship between neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and lymphocyte to monocyte ratio (LMR) and the prognostic and clinicopathological significance in patients with esophageal squamous cell carcinoma (ESCC) has been reported by many studies. However, inconsistent results have been presented. The current study aimed to investigate the prognostic and clinicopathological role of NLR, PLR, and LMR in patients with ESCC by meta-analysis. METHODS: Eligible studies were identified in databases and the relationship between NLR/PLR/LMR and the prognosis or clinicopathological features in patients with ESCC was evaluated. OR or HR with 95% CI was calculated to estimate the risk or hazard association. RESULT: Twenty-six studies including 8,586 ESCC patients were included for the analysis. We found that high NLR, PLR and low LMR were associated with poor overall survival/cancer-specific survival and event-free survival and malignant phenotypes such as deeper depth of invasion (T), positive lymph node metastasis (N), and advanced TNM stage. CONCLUSION: NLR, PLR, and LMR might serve as prognostic markers in patients with ESCC. |
format | Online Article Text |
id | pubmed-6257133 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-62571332018-12-11 The clinical use of pretreatment NLR, PLR, and LMR in patients with esophageal squamous cell carcinoma: evidence from a meta-analysis Sun, Yugui Zhang, Lifei Cancer Manag Res Original Research BACKGROUND AND PURPOSE: The relationship between neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and lymphocyte to monocyte ratio (LMR) and the prognostic and clinicopathological significance in patients with esophageal squamous cell carcinoma (ESCC) has been reported by many studies. However, inconsistent results have been presented. The current study aimed to investigate the prognostic and clinicopathological role of NLR, PLR, and LMR in patients with ESCC by meta-analysis. METHODS: Eligible studies were identified in databases and the relationship between NLR/PLR/LMR and the prognosis or clinicopathological features in patients with ESCC was evaluated. OR or HR with 95% CI was calculated to estimate the risk or hazard association. RESULT: Twenty-six studies including 8,586 ESCC patients were included for the analysis. We found that high NLR, PLR and low LMR were associated with poor overall survival/cancer-specific survival and event-free survival and malignant phenotypes such as deeper depth of invasion (T), positive lymph node metastasis (N), and advanced TNM stage. CONCLUSION: NLR, PLR, and LMR might serve as prognostic markers in patients with ESCC. Dove Medical Press 2018-11-22 /pmc/articles/PMC6257133/ /pubmed/30538564 http://dx.doi.org/10.2147/CMAR.S171035 Text en © 2018 Sun and Zhang. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Sun, Yugui Zhang, Lifei The clinical use of pretreatment NLR, PLR, and LMR in patients with esophageal squamous cell carcinoma: evidence from a meta-analysis |
title | The clinical use of pretreatment NLR, PLR, and LMR in patients with esophageal squamous cell carcinoma: evidence from a meta-analysis |
title_full | The clinical use of pretreatment NLR, PLR, and LMR in patients with esophageal squamous cell carcinoma: evidence from a meta-analysis |
title_fullStr | The clinical use of pretreatment NLR, PLR, and LMR in patients with esophageal squamous cell carcinoma: evidence from a meta-analysis |
title_full_unstemmed | The clinical use of pretreatment NLR, PLR, and LMR in patients with esophageal squamous cell carcinoma: evidence from a meta-analysis |
title_short | The clinical use of pretreatment NLR, PLR, and LMR in patients with esophageal squamous cell carcinoma: evidence from a meta-analysis |
title_sort | clinical use of pretreatment nlr, plr, and lmr in patients with esophageal squamous cell carcinoma: evidence from a meta-analysis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257133/ https://www.ncbi.nlm.nih.gov/pubmed/30538564 http://dx.doi.org/10.2147/CMAR.S171035 |
work_keys_str_mv | AT sunyugui theclinicaluseofpretreatmentnlrplrandlmrinpatientswithesophagealsquamouscellcarcinomaevidencefromametaanalysis AT zhanglifei theclinicaluseofpretreatmentnlrplrandlmrinpatientswithesophagealsquamouscellcarcinomaevidencefromametaanalysis AT sunyugui clinicaluseofpretreatmentnlrplrandlmrinpatientswithesophagealsquamouscellcarcinomaevidencefromametaanalysis AT zhanglifei clinicaluseofpretreatmentnlrplrandlmrinpatientswithesophagealsquamouscellcarcinomaevidencefromametaanalysis |